Floatz logo

TESTOSTERONE UNDECYLATE

Hypogonadotropic Hypogonadism

Canisius-Wilhelmina HospitalSmall moleculePhase 4 / ApprovedActive
A
82/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
74/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Hypogonadotropic Hypogonadism cohort.

Asset / SponsorPhaseRating
Metformin
University Medical Centre Ljubljana
Phase 4BBB
ANASTROZOLE
Baylor College of Medicine
Phase 4BBB
Liraglutide
University Medical Centre Ljubljana
Phase 4BB
Testim
Odense University Hospital
Phase 4BB
Androxal
Repros Therapeutics Inc.
Phase 3BB

View all 22 →

Same molecule, other indications

TESTOSTERONE UNDECYLATE is also rated in:

type 2 diabetes mellitusActive
BBB
Indicative · Phase 4
73 / 100
View asset →
sexual disorderDormant
BB
Indicative · Phase 3
69 / 100
View asset →
abdominal obesity-metabolic syndromeActive
BB
Indicative · Phase 4
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →